# | Filing Date | Period End Date | Type | Report Link |
---|---|---|---|---|
No Data found |
# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
Want to get the latest psychedelics industry news in your inbox every week? Subscribe to our Newsletter to become a Psychedelic...
Cybin Inc. (NEO:CYBN) (NYSE American: CYBE) announced that, through its wholly-owned subsidiary Cybin IRL Limited, It has enter...
The first Benzinga Psychedelics Capital Conference, the premier gathering of psychedelics industry leaders and forward-thinking...
Psychedelics biotech startup Entheon Biomedical (CSE: ENBI) (OTCQB: ENTBF) announced the approval by the local Dutch ethics com...
This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...
Psychedelics biotech company Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE:1XU1) has acquired Lobo Genetics Inc., a ...
This article was made possible thanks to invaluable research by Michael Haichin and Josh Hardman from Psilocybin Alpha. In jus...
Atai Life Sciences (NASDAQ: ATAI) made its highly-anticipated Nasdaq debut on Friday.
The Horizons Psychedelic Stock Index ETF is now listed on Toronto’s NEO exchange under the symbol ‘PSYK.’ PSYK is the first ex...